Biopharma | May 18, 2026
Kotak Alts invests Rs. 200 million in Cellogen Therapeutics
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
Dr. Reddy’s is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada
Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands
Approval strengthens the company’s growing international anti-infective portfolio
The company reported robust revenue and profit growth for FY26, supported by strong CDMO performance, improving margins, and expansion across advanced manufacturing platforms
The kidney care provider has established over 40 dialysis centres, delivering more than 40,000 dialysis sessions
Designed for high-throughput genomic analysis, the laboratory enables accurate, consistent, and scalable testing, delivering high standards of reporting excellence
Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
Subscribe To Our Newsletter & Stay Updated
